Acclinate, a Birmingham, AL-based company which specializes in mobilizing diverse communities for enhanced health equity, raised $17M in Series A funding.
The round was led by Cencora Ventures, with notable contributions from Labcorp and Latimer Ventures.
The company intends to use the funds to scale its impact in the clinical trial diversity and health equity landscapes.
Led by CEO Del Smith, Acclinate is a digital health company that leverages a combination of sustained community engagement and predictive analytics to improve health equity. Its community platform helps pharmaceutical companies increase diversity in their clinical trials and other healthcare organizations support inclusivity in their initiatives.
Commenting on the news, Del Smith said; “With the backing of prominent healthcare organizations like Cencora and Labcorp, we are poised to accelerate tangible change in the healthcare industry and empower diverse communities to proactively manage their health.”
FinSMEs
08/05/2024